AdvanSix (ASIX) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
29 Apr, 2026Executive summary
Annual meeting scheduled for June 22, 2026, with virtual participation available for shareholders.
Shareholders are encouraged to review proxy materials and vote on key proposals before June 21, 2026.
Voting matters and shareholder proposals
Election of eight directors, all recommended by the board for approval.
Ratification of PricewaterhouseCoopers LLP as independent registered public accountants for 2026.
Advisory vote on executive compensation, with board recommending approval.
Proxies have discretionary authority to vote on substitute nominees or other business arising at the meeting.
Board of directors and corporate governance
Director nominees include Jeffrey J. Bird, Erin N. Kane, Todd D. Karran, Gena C. Lovett, Donald P. Newman, Dana O'Brien, Daryl Roberts, Sharon S. Spurlin, and Patrick S. Williams.
Latest events from AdvanSix
- Sales up 3% on pricing, but earnings and cash flow fell sharply amid weak ag demand.ASIX
Q2 2026 - Diversified growth, operational efficiency, and strategic capital allocation drive a positive outlook.ASIX
CL King’s 22nd Annual Best Ideas Conference 2024 - All proposals, including director elections and auditor ratification, passed with strong support.ASIX
AGM 2026 - Expanding granular ammonium sulfate and DEF production to meet rising market demand.ASIX
Corporate presentation - Sales rose 7% to $404M, but higher costs drove net loss and margin compression in Q1 2026.ASIX
Q1 2026 - Proxy covers director elections, auditor ratification, say-on-pay, and highlights ESG leadership.ASIX
Proxy filing - Q4 sales up 9% with Plant Nutrients strength; 2026 focus on cost savings and cash flow.ASIX
Q4 2025 - Q3 sales up 23% to $398M; $12M USDA grant and Hopewell maintenance impact highlighted.ASIX
Q3 2024 - Q2 sales and earnings rose on strong nylon, ammonium sulfate, and acetone performance.ASIX
Q2 2024